Eli Lilly Adjusts Outlook, CEO David Ricks Explains Revenue Shortfall
Eli Lilly & Co. · PHARMACEUTICAL PREPARATIONS · Now $1082.20
+8.2% in 7d after detection
Post-detection moves
1h
—
1d
-0.2%
3d
+4.3%
7d
+8.2%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS